RxDoctor Payments Data

Constantinos Hadjipanayis

Neurological Surgery · Pittsburgh, PANPI 1457444754

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.8%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. NX Development Corp. accounts for 78.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $199,115 and has fallen 97.2% since, to $5,672 in 2025. Among neurological surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$483,986in general payments, 2019–2025

Across 106 payments — averaging $4565.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • NX Development Corp.$379K
  • Stryker$67K
  • Synaptive Medical Inc.$25K
  • Medical Investment Advisors LLC$4K
  • NICO Corporation$2K
  • Integra Lifesciences Corporation$2K
  • plus $3K from 8 others
$80,046in research payments, 2019–2025

Across 28 payments — averaging $2858.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Monteris Medical Corporation$43K
  • Stryker$25K
  • NICO Corporation$13K
  • Medtronic$25

What the payments were for

  • Royalty or licence$180,91737%
  • Consulting fees$289,21760%
  • Speaking & faculty fees$1,0000%
  • Travel & lodging$10,3522%
  • Food & beverage$2,4821%
  • Gifts$170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
NX Development Corp.4$379,447
Stryker54$66,648
Synaptive Medical Inc.12$25,485
Medical Investment Advisors LLC2$4,357
NICO Corporation1$2,400
Integra Lifesciences Corporation4$2,149
Carl Zeiss Meditec, Inc.3$1,517
Elekta, Inc.5$844
Monteris Medical Corporation13$417
Medtronic4$347
Omniscient Neurotechnology America Ltd1$184
Leica Microsystems Inc.1$107
Spineart USA Inc1$44
Insightec,inc1$39

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$483,986 in reported general payments places this provider in the 95th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$96,311
Medicare patients
73
Services billed
220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam12$231

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →